| LY3039478 |
CRENIGACESTAT |
1421438-81-4 |
| Mutant EGFR inhibitor |
N-[5-[[5-氯-4-(1H-吲哚-3-基)-2-嘧啶基]氨基]-2-[[2-(二甲基氨基)乙基]甲基氨基]-4-甲氧基苯基]-2-丙烯酰胺 |
1421373-62-7 |
| AZ-5104 |
奥西替尼中间体 |
1421373-98-9 |
| PTC-209 (hydrobroMide) |
PTC-209HBR |
1217022-63-3 |
| ICI-118551 |
ICI-118551 |
1217094-53-5 |
| O-Propargyl-PuroMycin |
1416561-90-4 |
1416561-90-4 |
| Btk inhibitor 1 |
1412418-47-3 |
1412418-47-3 |
| 7H-Pyrrolo[3,2-f]quinazoline-1,3-diaMine, N3-cyclopropyl-7-[[4-(1-Methylethyl)phenyl]Methyl]-, (Hydrochloride) (1:2) |
SCH79797 DIHYDROCHLORIDE |
1216720-69-2 |
| CCT 244747 |
3-[(1R)-2-(二甲基氨基)-1-甲基乙氧基]-5-[[4-甲氧基-5-(1-甲基-1H-吡唑-4-基)-2-吡啶基]氨基]-2-吡嗪甲腈 |
1404095-34-6 |
| GLPG0492 (R enantiomer) |
1215085-93-0 |
1215085-93-0 |
| Ningetinib Tosylate |
对甲苯磺酸宁格替尼 |
1394820-77-9 |
| MK-8722 |
(3S,3AS,6S,6AS)-6-((5-([1,1'-联苯]-4-基)-6-氯-1H-咪唑并[4,5-B]吡啶-2-基)氧基)六氢呋喃[3,2-B]呋喃-3-醇 |
1394371-71-1 |
| Ningetinib |
宁格替尼 |
1394820-69-9 |
| GSK J2 |
N-[2-(3-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸 |
1394854-52-4 |
| (R)-MG132 |
N-[(苯基甲氧基)羰基]-L-亮氨酰-N-[(1S)-1-甲酰基-3-甲基丁基]-D-亮氨酰胺 |
1211877-36-9 |
| Lemborexant |
莱博雷生 |
1369764-02-2 |
| Senexin A |
SENEXIN A |
1366002-50-7 |
| BenzenesulfonaMide, 3-chloro-2-Methyl-N-[5,6,7,8-tetrahydro-2-[(2-phenylethyl)aMino]-6-(phenylMethyl)pyrido[4,3-d]pyriMidin-4-yl]- |
3-氯-2-甲基-N-[5,6,7,8-四氢-2-[(2-苯基乙基)氨基]-6-(苯基甲基)吡啶并[4,3-D]嘧啶-4-基]苯磺酰胺 |
1208123-85-6 |
| HVANMRCHFMTSEG-LREBCSMRSA-N |
HVANMRCHFMTSEG-LREBCSMRSA-N |
1207859-16-2 |
| LGD-6972 |
1207989-09-0 |
1207989-09-0 |
